Tóth, L.I.; Harsányi, A.; Csiha, S.; Molnár, Á.; Lőrincz, H.; Nagy, A.C.; Paragh, G.; Harangi, M.; Sztanek, F.
Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study. Int. J. Mol. Sci. 2025, 26, 5951.
https://doi.org/10.3390/ijms26135951
AMA Style
Tóth LI, Harsányi A, Csiha S, Molnár Á, Lőrincz H, Nagy AC, Paragh G, Harangi M, Sztanek F.
Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study. International Journal of Molecular Sciences. 2025; 26(13):5951.
https://doi.org/10.3390/ijms26135951
Chicago/Turabian Style
Tóth, László Imre, Adrienn Harsányi, Sára Csiha, Ágnes Molnár, Hajnalka Lőrincz, Attila Csaba Nagy, György Paragh, Mariann Harangi, and Ferenc Sztanek.
2025. "Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study" International Journal of Molecular Sciences 26, no. 13: 5951.
https://doi.org/10.3390/ijms26135951
APA Style
Tóth, L. I., Harsányi, A., Csiha, S., Molnár, Á., Lőrincz, H., Nagy, A. C., Paragh, G., Harangi, M., & Sztanek, F.
(2025). Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study. International Journal of Molecular Sciences, 26(13), 5951.
https://doi.org/10.3390/ijms26135951